Kennedy Krieger Institute

Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem

Turning disadvantages into advantages to treat brain disorders Tumors require nutrients from the blood supply in order to proliferate. They therefore secrete small amounts of biochemical messengers to